Abstract
Antibodies are natural nanomaterials and have been widely used for targeted cell labeling. However, the applications of antibodies are often limited by their large size and instability. The purpose of this study is to develop a new type of multifunctional nanomaterial that is comprised of a nucleic acid aptamer and a dendrimer, both of which are stable. This nanomaterial is ≈8 nm in size. Moreover, it could not only carry multiple signal molecules, but also bind to target cancer cells with high affinity and specificity. This sub-10nm multifunctional nanomaterial is expected to be useful in basic biomedical research and clinical medicine. (Figure Presented)
| Original language | English (US) |
|---|---|
| Pages (from-to) | 831-835 |
| Number of pages | 5 |
| Journal | Macromolecular Bioscience |
| Volume | 9 |
| Issue number | 9 |
| DOIs | |
| State | Published - Sep 9 2009 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Biotechnology
- Bioengineering
- Biomaterials
- Polymers and Plastics
- Materials Chemistry
Fingerprint
Dive into the research topics of 'A hybrid DNA aptamer-dendrimer nanomaterial for targeted cell labeling'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver